Physician profile
Hashir Saeed
NPI 1902251929
$2,453.98
in general payments reported to CMS, 2019-2025
10 companies · $476 in 2025
The $476 reported for 2025 was more than what 79% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $528 · 2023: $707 · 2024: $743 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,926.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,925.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $806.22 | 2022-2025 | Spinejack, Omnicurve, Optablate |
| Inari Medical, INC. | $425.34 | 2022-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $418.04 | 2022-2024 | Indigo System |
| Boston Scientific Corporation | $209.51 | 2023 | Ekosonic |
| Medtronic, INC. | $149.84 | 2023-2024 | In.Pact Admiral, Abre |
| Bard Peripheral Vascular, INC. | $142.59 | 2022 | |
| W. L. Gore & Associates, INC. | $127.19 | 2022 | |
| Shockwave Medical, INC | $80.44 | 2023-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Surmodics, INC. | $50.56 | 2023-2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Pounce Venous Thrombectomy System |
| Angiodynamics, INC. | $44.25 | 2023-2025 | Auryon Laser System 100-120 Vac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hashir Saeed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.